Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
15:10
15:40
We will explore some of the cutting-edge advancements in our antibody discovery and engineering appr
...
Bi/Multispecifics
11:20
12:20
Formats & Scaffolds
11:20
12:20
Lead Identification & Optimization
Lead Identification & Optimization
11:20
12:20
Optimizing protein therapeutics for clinical success: How can incorporating developability assessmen
...
Target Selection & Mechanisms of Action
Target Selection & Mechanisms of Action
09:05
10:05
What engineering strategies are used to enhance membrane antigen presentation, and why are they impo
...
Target Selection & Mechanisms of Action
Target Selection & Mechanisms of Action
15:50
16:20
As the world leader in antibody services, our decades of research experience converge with advanced
...
Formats & Scaffolds
15:50
16:20
Bi/Multispecifics
15:50
16:20
Efficient bispecific antibody (bsAb) production requires precise assembly of multiple chains. Combin
...
Lead Identification & Optimization
Lead Identification & Optimization
15:50
16:20
The PioneerTM Antibody Discovery Platform is Bio-Rad’s new service for biotherapeutic lead generatio
...
Formats & Scaffolds
09:05
10:05
How to solve the challenges of small therapeutic windows for cytokine treatment Manufacturing and st
...
Bi/Multispecifics
16:20
17:20
How do translational efficacy and safety assessments contribute to the selection of optimal molecule
...
Lead Identification & Optimization
Lead Identification & Optimization
09:05
10:05
Are current antibody discovery platforms and screening strategies meeting our expectations for effec
...
Target Selection & Mechanisms of Action
Target Selection & Mechanisms of Action
11:20
12:20
What characteristics make a protein a “clean” target in terms of avoiding the off-target effects of
...
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
13:25
13:55
Aureka Biotechnologies is a pioneer in the next generation of antibody discovery and engineering via our three fundamental technologies. Our platforms integrate AI with high-throughput biology for a fast, closed-loop, integrative discovery process. AuraQuest accelerates antibody design via a unique synthetic biology design, while AuraGlow, an ultra-high-throughput screening system, evaluates functional performance. AuraPicasso, our generative AI engine, continuously refines antibody candidates using feedback from AuraQuest and AuraGlow. This closed-loop system enables fast iteration, ensuring the development of best-in-class therapeutics with enhanced efficacy and specificity. To date, we have delivered on challenges such as pH sensitive binders, dual-affinity molecules, and AI-first therapeutics.
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
17:20
18:20
Drinks-Canape Reception
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
15:40
15:50
Afternoon Refreshments
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
14:00
14:30
1-2-1 Meetings / Networking Break
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
14:35
15:05
1-2-1 Meetings / Networking Break
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
12:20
13:20
Networking Lunch
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
11:10
11:20
Morning Refreshments
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
10:40
11:10
1-2-1 Meetings / Networking Break
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
10:10
10:40
1-2-1 Meetings / Networking Break
Bi/Multispecifics
09:05
10:05
How do the structural formats of bispecific antibodies impact their stability, expression levels, an
...
Lead Identification & Optimization
Lead Identification & Optimization
16:20
17:20
Where does AI stand on de novo antibody design? How can human BCR and single cell sequencing data i
...
Target Selection and Mechanisms of Action
Target Selection & Mechanisms of Action
16:20
17:20
What are some challenges in affinity maturation of antibodies against membrane proteins and how have
...
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
08:30
09:00
Off-target binding is a significant hurdle in the development of antibody-based therapies, contribut
...
Bi/Multispecifics
Formats & Scaffolds
Lead Identification & Optimization
Target Selection & Mechanisms of Action
08:00
08:30
Registration
)
We will explore some of the cutting-edge advancements in our antibody discovery and engineering appr ...
)
)
Aureka Biotechnologies is a pioneer in the next generation of antibody discovery and engineering via our three fundamental technologies. Our platforms integrate AI with high-throughput biology for a fast, closed-loop, integrative discovery process. AuraQuest accelerates antibody design via a unique synthetic biology design, while AuraGlow, an ultra-high-throughput screening system, evaluates functional performance. AuraPicasso, our generative AI engine, continuously refines antibody candidates using feedback from AuraQuest and AuraGlow. This closed-loop system enables fast iteration, ensuring the development of best-in-class therapeutics with enhanced efficacy and specificity. To date, we have delivered on challenges such as pH sensitive binders, dual-affinity molecules, and AI-first therapeutics.)
Off-target binding is a significant hurdle in the development of antibody-based therapies, contribut ...
)
)
)
)
)
)
)
)
)
)
)
)
)
)